Carlson Joseph, Roh Michael H, Chang Martin C, Crum Christopher P
Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Diagn Histopathol (Oxf). 2008 Aug;14(8):352-365. doi: 10.1016/j.mpdhp.2008.06.009.
In the past 50 years, the concept of serous ovarian cancer has been progressively refined, with the distinction of the borderline serous tumour, identification of a smaller subset of well-differentiated serous malignancies and, recently, closer attention to the pathogenesis of high-grade serous malignancies. High-grade serous carcinoma, traditionally presumed to arise within Müllerian inclusion cysts of the ovarian surface, cortex and peritoneum, has recently been linked to the distal fallopian tube. This review addresses the disparate forms of serous neoplasia, which reflect both different genetic abnormalities and stages of differentiation of Müllerian epithelium. The significance of these different origins is addressed in the context of ovarian cancer prevention.
在过去50年里,浆液性卵巢癌的概念逐渐得到完善,包括交界性浆液性肿瘤的区分、高分化浆液性恶性肿瘤较小亚组的识别,以及近来对高级别浆液性恶性肿瘤发病机制的密切关注。传统上认为高级别浆液性癌起源于卵巢表面、皮质和腹膜的米勒管包涵囊肿,最近发现其与远端输卵管有关。本文综述了浆液性肿瘤的不同形式,这些形式反映了米勒管上皮不同的基因异常和分化阶段。在卵巢癌预防的背景下讨论了这些不同起源的意义。